Home   |   Print Page   |   Contact Us   |   Join MSDC
News & Press: National

100 Best-Selling, Most Prescribed Branded Drugs Through March 2015

Wednesday, May 13, 2015  
Posted by: Pia Duryea
Share |
From Medscape Medical News

The hypothyroid drug levothyroxine (Synthroid, AbbVie) was the most prescribed drug in the United States, and the arthritis drug adalimumab (Humira, Abbott Laboratories) was the best-selling drug through March of this year, according to recent data.

Research firm IMS released a rolling 12-month history of prescription numbers and total sales from April 2014 through March 2015.

Levothyroxine had about 21.6 million prescriptions, followed by cholesterol-lowering drug rosuvastatin (Crestor, AstraZeneca), at about 21.5 million prescriptions; asthma medication albuterol (Ventolin HFA, GlaxoSmithKline), at about 18.2 million prescriptions; proton pump inhibitor esomeprazole (Nexium, AstraZeneca), at about 15.3 million prescriptions; and asthma medication fluticasone propionate/salmeterol (Advair Diskus, GlaxoSmithKline), at about 13.8 million prescriptions.

The remaining top 10 most prescribed drugs for the period (in order) were the insulin glargine injection (Lantus Solostar, sanofi-aventis), the attention-deficit drug lisdexamfetamine dimesylate (Vyvanse, Shire), the antiepileptic drug pregabalin (Lyrica, Pfizer), the chronic obstructive pulmonary disease medication tiotropium bromide (Spiriva Handihaler, Boehringer Ingelheim Pharmaceuticals), and the diabetes drug sitagliptin (Januvia, Merck).

 

Read more in Medscape Medical News.


Association Management Software Powered by YourMembership  ::  Legal